Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T15:41:58.421Z.
Calculation as of: 2026-10-06T15:41:58.421Z.
Quote observation: 2026-10-06T15:40:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e02887d9f7d553dead588493e3d1cc1cda6164751857f77264c258b40fe63259
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-07-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Fulcrum Therapeutics, Inc.
Market Cap
$283.44M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$280.29M
Price/OCF Ratio
N/A
TTM Avg
108.55
3Y Avg
108.55
5Y Avg
108.55
Market Cap
$287.63M
Price/OCF Ratio
N/A
TTM Avg
2.51
3Y Avg
2.51
5Y Avg
2.51
Market Cap
$288.54M
Price/OCF Ratio
N/A
TTM Avg
4132.33
3Y Avg
4132.33
5Y Avg
4132.33
Market Cap
$291.19M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$271.23M
Price/OCF Ratio
N/A
TTM Avg
134.67
3Y Avg
134.67
5Y Avg
134.67
Market Cap
$297.62M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | $283.44M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $280.29M | N/A | 108.55 | 108.55 | 108.55 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $287.63M | N/A | 2.51 | 2.51 | 2.51 |
| Fate Therapeutics, Inc. (FATE)vs › | $278.58M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.54M | N/A | 4132.33 | 4132.33 | 4132.33 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $291.19M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $291.48M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $271.23M | N/A | 134.67 | 134.67 | 134.67 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $268.17M | N/A | 64.10 | 34.63 | 150.74 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2025-07-29 | 60.73 |
| 2025-07-28 | 62.49 |
| 2025-07-25 | 62.49 |
| 2025-07-24 | 62.57 |
| 2025-07-23 | 63.29 |
| 2025-07-22 | 56.41 |
| 2025-07-21 | 56.81 |
| 2025-07-18 | 61.21 |
| 2025-07-17 | 63.53 |
| 2025-07-16 | 63.05 |
| 2025-07-15 | 62.73 |
| 2025-07-14 | 63.21 |
| 2025-07-11 | 62.65 |
| 2025-07-10 | 64.09 |
| 2025-07-09 | 63.29 |
| 2025-07-08 | 62.81 |
| 2025-07-07 | 56.17 |
| 2025-07-03 | 55.37 |
| 2025-07-02 | 55.45 |
| 2025-07-01 | 54.73 |
| 2025-06-30 | 55.05 |
| 2025-06-27 | 56.81 |
| 2025-06-26 | 59.05 |
| 2025-06-25 | 57.29 |
| 2025-06-24 | 57.53 |
| 2025-06-23 | 57.37 |
| 2025-06-20 | 56.01 |
| 2025-06-18 | 50.89 |
| 2025-06-17 | 51.45 |
| 2025-06-16 | 54.41 |
| 2025-06-13 | 54.81 |
| 2025-06-12 | 54.25 |
| 2025-06-11 | 54.65 |
| 2025-06-10 | 55.21 |
| 2025-06-09 | 56.97 |
| 2025-06-06 | 58.01 |
| 2025-06-05 | 56.89 |
| 2025-06-04 | 56.25 |
| 2025-06-03 | 56.33 |
| 2025-06-02 | 55.69 |
| 2025-05-30 | 55.05 |
| 2025-05-29 | 56.57 |
| 2025-05-28 | 55.21 |
| 2025-05-27 | 50.81 |
| 2025-05-23 | 51.53 |
| 2025-05-22 | 48.97 |
| 2025-05-21 | 50.01 |
| 2025-05-20 | 52.09 |
| 2025-05-19 | 55.45 |
| 2025-05-16 | 55.05 |
| 2025-05-15 | 52.81 |
| 2025-05-14 | 45.05 |
| 2025-05-13 | 46.33 |
| 2025-05-12 | 45.45 |
| 2025-05-09 | 42.96 |
| 2025-05-08 | 43.28 |
| 2025-05-07 | 40.56 |
| 2025-05-06 | 42.80 |
| 2025-05-05 | 45.85 |
| 2025-05-02 | 44.97 |
